FACTORS OF ACCESS TO THE MARKET OF INNOVATIVE SPECIALTIES IN ALGERIA: THE CASE OF HOSPITAL DRUGS

被引：0
|
作者：
Djafri, R. [1 ]
Djemai, S. [1 ]
Aissaoui, A. [2 ]
Laichour, A. [2 ]
Boudis, A. [1 ]
机构：
[1] Fac Pharm, Algiers, Algeria
[2] Sanofi, Algiers, Algeria
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR145
引用
收藏
页码：S258 / S259
页数：2
相关论文
共 50 条
  • [1] MARKET ACCESS OF INNOVATIVE ANTICANCER DRUGS IN ALGERIA: FUNDING BASED ON CLINICAL OR ECONOMIC EVIDENCE?
    Aissaoui, A.
    Kaddar, M.
    Soualmi, R.
    VALUE IN HEALTH, 2016, 19 (07) : A759 - A759
  • [2] Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
    Pauwels, Kim
    Huys, Isabelle
    Casteels, Minne
    Simoens, Steven
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [3] TIME TO MARKET ACCESS FOR INNOVATIVE DRUGS IN THE UK, FRANCE, AND BELGIUM
    Maervoet, J.
    Toumi, M.
    VALUE IN HEALTH, 2012, 15 (07) : A312 - A312
  • [4] MARKET ACCESS TIMELINES TO INNOVATION IN ALGERIA
    Meriem, H.
    Sadeddine, H.
    Charmati, A.
    Ghanassi, F. Z.
    VALUE IN HEALTH, 2022, 25 (07) : S540 - S540
  • [5] MARKET ACCESS AGREEMENTS: IMPLEMENTATION IN ALGERIA
    Meriem, H.
    Arroudj, H.
    Hellal, N.
    Loumi, O.
    VALUE IN HEALTH, 2020, 23 : S658 - S658
  • [6] THE ACCESS AND THE DIFFUSION OF ONCOLOGY DRUGS IN ALGERIA
    Aissaoui, A.
    Kaddar, M.
    Soualmi, R.
    VALUE IN HEALTH, 2015, 18 (03) : A216 - A216
  • [7] CAN PRICING SCHEMES IMPROVE MARKET ACCESS FOR INNOVATIVE HIGH PRICED DRUGS?
    Anastasaki, E.
    Colasante, W.
    Imbeah-Ampiah, R.
    VALUE IN HEALTH, 2011, 14 (03) : A17 - A17
  • [8] Influence of market access conditions on utilization of innovative drugs in Europe: Example of bevacizumab.
    Toumi, M.
    Misset, J.
    Krukowski, L.
    Aballea, S.
    Lamure, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Influence of market access conditions on utilization of innovative drugs in Europe: The cases of trastuzumab and cetuximab
    Misset, J.
    Toumi, M.
    Krukowski, L.
    Lamure, M.
    Aballea, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] CONSUMPTION AND ACCESS TO INNOVATIVE CANCER DRUGS IN SLOVAKIA
    Tomek, D.
    Bielik, J.
    VALUE IN HEALTH, 2008, 11 (06) : A491 - A492
12345